FLT3 and acute myeloid leukemia: Although mutations in several genes, such as FLT3, CEBPA, NPM1, TP53, RUNX1 and ASXL1, have been well established to occur in AML, the current understanding of the molecular mechanisms involved in the development and progression of AML is still limited [3].